Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
412 | 16030 | 43.6 | 87% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
261 | 41136 | GENE DELIVERY//GENE THERAPY//ANTIMICROBIAL PEPTIDE |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GENE DELIVERY | Author keyword | 721 | 43% | 8% | 1271 |
2 | GENE THERAPY | Author keyword | 303 | 14% | 12% | 1991 |
3 | POLYETHYLENIMINE | Author keyword | 244 | 42% | 3% | 443 |
4 | ADENO ASSOCIATED VIRUS | Author keyword | 211 | 40% | 3% | 417 |
5 | LIPOPLEX | Author keyword | 207 | 76% | 1% | 144 |
6 | HUMAN GENE THERAPY | Journal | 205 | 24% | 5% | 759 |
7 | CATIONIC LIPIDS | Author keyword | 204 | 67% | 1% | 183 |
8 | CATIONIC LIPID | Author keyword | 198 | 66% | 1% | 184 |
9 | POLYPLEX | Author keyword | 185 | 74% | 1% | 139 |
10 | ADENOVIRUS | Author keyword | 172 | 18% | 5% | 875 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GENE DELIVERY | 721 | 43% | 8% | 1271 | Search GENE+DELIVERY | Search GENE+DELIVERY |
2 | GENE THERAPY | 303 | 14% | 12% | 1991 | Search GENE+THERAPY | Search GENE+THERAPY |
3 | POLYETHYLENIMINE | 244 | 42% | 3% | 443 | Search POLYETHYLENIMINE | Search POLYETHYLENIMINE |
4 | ADENO ASSOCIATED VIRUS | 211 | 40% | 3% | 417 | Search ADENO+ASSOCIATED+VIRUS | Search ADENO+ASSOCIATED+VIRUS |
5 | LIPOPLEX | 207 | 76% | 1% | 144 | Search LIPOPLEX | Search LIPOPLEX |
6 | CATIONIC LIPIDS | 204 | 67% | 1% | 183 | Search CATIONIC+LIPIDS | Search CATIONIC+LIPIDS |
7 | CATIONIC LIPID | 198 | 66% | 1% | 184 | Search CATIONIC+LIPID | Search CATIONIC+LIPID |
8 | POLYPLEX | 185 | 74% | 1% | 139 | Search POLYPLEX | Search POLYPLEX |
9 | ADENOVIRUS | 172 | 18% | 5% | 875 | Search ADENOVIRUS | Search ADENOVIRUS |
10 | CATIONIC LIPOSOME | 170 | 58% | 1% | 194 | Search CATIONIC+LIPOSOME | Search CATIONIC+LIPOSOME |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POLYETHYLENIMINE | 764 | 57% | 6% | 913 |
2 | TRANSFECTION EFFICIENCY | 717 | 61% | 5% | 755 |
3 | DNA COMPLEXES | 508 | 63% | 3% | 513 |
4 | PLASMID DNA | 477 | 24% | 11% | 1730 |
5 | TRANSFECTION | 424 | 30% | 7% | 1193 |
6 | DNA DELIVERY | 403 | 58% | 3% | 471 |
7 | POLYPLEXES | 329 | 73% | 2% | 254 |
8 | TRANSGENE EXPRESSION | 319 | 29% | 6% | 938 |
9 | ADENOASSOCIATED VIRUS | 288 | 38% | 4% | 592 |
10 | GENE DELIVERY | 280 | 19% | 9% | 1364 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENE THERAPY | 223 | 23% | 5% | 861 |
2 | HUMAN GENE THERAPY | 205 | 24% | 5% | 759 |
3 | MOLECULAR THERAPY | 132 | 19% | 4% | 627 |
4 | JOURNAL OF GENE MEDICINE | 131 | 29% | 2% | 390 |
5 | CURRENT GENE THERAPY | 18 | 18% | 1% | 91 |
6 | HUMAN GENE THERAPY METHODS | 16 | 32% | 0% | 40 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Nonviral Vectors for Gene Delivery | 2009 | 865 | 526 | 58% |
Non-viral vectors for gene-based therapy | 2014 | 89 | 148 | 47% |
Design and development of polymers for gene delivery | 2005 | 1051 | 165 | 78% |
Toxicity of cationic lipids and cationic polymers in gene delivery | 2006 | 586 | 95 | 88% |
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges | 2011 | 210 | 158 | 59% |
Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives | 2005 | 484 | 151 | 86% |
Adeno-Associated Virus Vectors and Neurological Gene Therapy | 2015 | 4 | 92 | 60% |
Synthetic DNA delivery systems | 2000 | 974 | 73 | 68% |
Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses | 2012 | 107 | 77 | 75% |
The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic | 2009 | 375 | 33 | 55% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENE THER Y | 151 | 23% | 3.6% | 577 |
2 | HUMAN GENE THER Y | 74 | 30% | 1.3% | 205 |
3 | GENE TRANSFER REGULAT | 63 | 70% | 0.3% | 53 |
4 | POWELL GENE THER Y | 50 | 37% | 0.7% | 109 |
5 | GENE THER Y PROGRAM | 48 | 28% | 0.9% | 144 |
6 | SYST BASED DRUG | 44 | 77% | 0.2% | 30 |
7 | MOL MED GENE THER Y UNIT | 35 | 67% | 0.2% | 31 |
8 | DRUG DELIVERY | 34 | 17% | 1.2% | 187 |
9 | BIOPHARMACEUT DRUG METAB | 34 | 42% | 0.4% | 63 |
10 | PHARMACEUT BIOPHARM | 32 | 32% | 0.5% | 84 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000025108 | CELL PENETRATING PEPTIDE//CELL PENETRATING PEPTIDES//PROTEIN TRANSDUCTION DOMAINS |
2 | 0.0000023097 | ONCOLYTIC VIRUS//VIROTHERAPY//CYTOSINE DEAMINASE |
3 | 0.0000019773 | E1A//BIOL MOL ELADIO VINUELA//PHAGE PHI 29 |
4 | 0.0000013941 | PIRNA//RNA INTERFERENCE//PIWI |
5 | 0.0000009473 | EPIDEMIC KERATOCONJUNCTIVITIS//HIGH LEVEL DISINFECTION//OPHTHALMOLHOWE |
6 | 0.0000008433 | SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//NANOSUSPENSION |
7 | 0.0000007913 | HPMA COPOLYMERS//HPMA COPOLYMER//PEGYLATION |
8 | 0.0000007879 | MARINER//SLEEPING BEAUTY//TRANSGENIC CHICKEN |
9 | 0.0000007651 | CHITOSAN//YKL 40//CHITINASE |
10 | 0.0000006843 | APOBEC3G//INTEGRASE//HIV 1 INTEGRASE |